| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |